Raymond James Reinstates Outperform on CareTrust REIT, Announces $43 Price Target
CareTrust REIT, Inc.
CareTrust REIT, Inc. CTRE | 0.00 |
Raymond James analyst David Rodgers reinstates CareTrust REIT (NYSE:
CTRE) with a Outperform and announces $43 price target.
